Roche to use Isis's technology to develop brain disorder drug

(Reuters) - Isis Pharmaceuticals Inc said it will form an alliance with Swiss drugmaker Roche Holding AG to develop treatments for Huntington's disease, a genetic brain disorder, based on the U.S. company's technology.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news